Classical and emergent measures for clinical trials in ALS

Amyotroph Lateral Scler Other Motor Neuron Disord. 2002:3 Suppl 1:S1-2. doi: 10.1080/146608202320374110.
No abstract available

MeSH terms

  • Amyotrophic Lateral Sclerosis / drug therapy*
  • Amyotrophic Lateral Sclerosis / pathology
  • Amyotrophic Lateral Sclerosis / physiopathology
  • Cost-Benefit Analysis
  • Endpoint Determination
  • Humans
  • Magnetic Resonance Imaging
  • Muscle, Skeletal / physiopathology
  • Research Design
  • Survival